D-0679-2026 Class II Ongoing

Recalled by Bell Pharmaceuticals, Inc — Belle Plaine, MN

FDA drug recall D-0679-2026 was initiated by Bell Pharmaceuticals, Inc on Jun 25, 2026 and is designated Class II. Reason for recall: SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%). The recall status is ongoing. Affected quantity: 29, 474 units.

Recall details

Product Type
Drugs
Report Date
Jul 22, 2026
Initiation Date
Jun 25, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
29, 474 units

Product description

Clinere, Carbamide Peroxide, a) 2 bottles of Clinere Carbamide Peroxide (2 x 0.50 mL) 6.5%, 0.5 fl. oz. (15 mL); b) 1 bottle of Clinere Carbamide Peroxide (0,50 fl. oz. (15 mL), Dist. by: Quest Products LLC, Pleasant Prairie, WI 53158, NDC 68229-102-01.

Reason for recall

SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).

Distribution pattern

U.S Nationwide

Code information

Lot: a) 1504241, exp 2027-03; b) 1504291, 1504301, exp 2027-03.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0679-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0679-2026. Report a data issue: hello@regdatalab.com.